Tell the Truth About Antidepressants On Drug Labels & in Medical Journals Thu, 16 Sep 2004 An April, 2004 editorial in the New York Times noted: “What seems most astonishing is the skimpy evidence that these drugs work at all in most young patients.” What is astonishing is how the…
A request for comment about NIH proposed new research misconduct rule
See Fed Register:
http://ori.dhhs.gov/multimedia/acrobat/42CFRParts50and93.pdf
The new rule, I believe is meant to protect research institutions from the effective sting of a knowledgeable whistle blower.
The new rule would redefine whistle-blower as “complainant” and would limit the role of the complainant. Under the old rule, the whistle-blower participated in the process helping investigators by leading them to the evidence, etc.
Unlawful drug marketing: GlaxoSmithKline & 4,000 doctors Face Criminal Charges in Italy Mon, 7 Jun 2004 On March 25, 2004, the US Attorney in Pennsylvania commenced an investigation of Eli Lilly’s marketing promotion of Zyprexa (olanzapine), Prozac (fluoxetine) and Evista (raloxifene). On April 19, a class action lawsuit was filed…
Two Court Rulings Reject Pfizer-FDA Preemption Claim in Zoloft “failure to warn” cases Thu, 21 Jul 2005 In a stunning federal court order JAMES M. ROSENBAUM, US Chief District Judge in Minnesota, overturned FDA-supported pre-emption arguments in their entirety! “The FDA has no authority to declare, ipse dixit, that a…
Sen Domenici Blasts NIH doctors calling them “pigs” – The Hill Thu, 18 Mar 2004 The shameful revelations of insatiable greed among medical researchers at the National Institutes of Health has disgusted Sen. Pete Domenici, one of the strongest supporters of medical research. “I hate to say it, but the…
Tue, 30 Nov 2004 Tonight the BBC- 2 is airing an investigative report about a series of drug experiments that were conducted on infants and children who were under the guardianship of the New York City Agency for Children’s Services (ACS), and living at Incarnation Children’s Center, a foster care…
ALLIANCE FOR HUMAN RESEARCH PROTECTION Homepage 142 West End Ave. Suite 28P New York, NY 10023 March 10, 2004 Dr. Michael Carome Chief of Compliance Office of Human Research Protections David Horowitz Director, Office of Compliance Food & Drug Administration Dept. of Health and Human Services cc: Dr. Bernard Schwetz,…
RE: Phase I Drug trials used foster children in violation of 45 CFR 46.409 and 21 CFR 50.56
The Alliance for Human Research Protection (AHRP) has reason to believe that federal regulations for the protection of children as research subjects have been seriously violated in federally funded HIV research.
We have learned that a series of Phase I and Phase II drug experiments were conducted on infants and children who were under the guardianship of the New York City Agency for Children’s Services (ACS), and living at Incarnation Children’s Center, a foster care facility under contract with ACS.
Ethics Policy Announced for NIH Officials – LAT Tue, 2 Mar 2004 This is a case demonstrating the power of the press ( the “fourth estate”) in its most important role providing a check on the abuse of government power. An investigative report by David Willman, Pulitzer Prize winning journalist…
TeenScreen – Angel of Mercy or Pill-Pusher for Drug Industry Thu, 14 Apr 2005 An investigative reporter has dug up the facts behind TeenScreen, the aggressive marketing scheme that targets America’s school children who are being “screened” for undetected mental problems – even though no accurate diagnostic screening tool for…
KAREN VAN LANDEGHEM: E7 – Comprehensive Children’s Mental Health Systems (GEN) – March 1, 2004 http://128.248.232.90/archives/mchb/amchp2004/e7/transcripts/session19b.htm KAREN VAN LANDEGHEM: Good afternoon. I want to thank AMCHP for inviting Illinois to be here and I, I need to say that, actually Barbara Shaw who’s the chair of the Illinois Children’s Mental…
HIV Foster Babies, Children Used to test safety of Experimental Drugs – NY Post Sun, 29 Feb 2004 As a society, we need to be concerned that too many within the medical research community seem to have abandoned the foremost principle of medical ethics: First, do no harm. The latest…
